AEDV Registry of Primary Cutaneous Lymphoma
NCT03646422 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2022-03-31
Summary
Registry of patients with Primary Cutaneous Lymphoma seen at participating centers in Spain. The registry will identify patients with this disease and includes information about stage, diagnostic and therapeutic interventions and willingness to participate in further studies.
Conditions
- Lymphoma, T-Cell, Cutaneous
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Large B-Cell, Diffuse
- Sezary Syndrome
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, B-Cell
Interventions
- OTHER
-
Registry of patients (exposure is Cutaneous Lymphoma)
Sponsors & Collaborators
-
Fundación Academia Española de Dermatología
lead OTHER
Principal Investigators
-
Pablo Ortiz, MD, PhD · Hospital 12 de Octubre
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-01
- Primary Completion
- 2025-01-01
- Completion
- 2025-01-01
Countries
- Spain
Study Locations
More Related Trials
-
Local Registry of Primary Cutaneous T-cell Lymphomas
NCT07160023 ·Status: RECRUITING
-
A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin
NCT04998331 ·Status: COMPLETED
-
Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma
NCT05772624 ·Status: UNKNOWN ·Phase: PHASE2
-
Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas
NCT04520529 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
NCT01369784 ·Status: COMPLETED
-
A Registry for People With T-cell Lymphoma
NCT05978141 ·Status: RECRUITING
-
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
NCT02618109 ·Status: TERMINATED ·Phase: PHASE4
-
Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions
NCT02867553 ·Status: UNKNOWN ·Phase: PHASE3
-
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
NCT06424379 ·Status: ACTIVE_NOT_RECRUITING
-
Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma
NCT04183569 ·Status: UNKNOWN
-
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT04384484 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients
NCT01056679 ·Status: COMPLETED ·Phase: PHASE1
-
Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis
NCT02520908 ·Status: ACTIVE_NOT_RECRUITING
-
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.
NCT05249959 ·Status: RECRUITING ·Phase: PHASE2
-
An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme
NCT06734078 ·Status: ACTIVE_NOT_RECRUITING
-
Application of Telemedicine to the Management of Aggressive Lymphomas
NCT03336138 ·Status: COMPLETED ·Phase: NA
-
Study on Plasmablastic Lymphoma Patients
NCT06781359 ·Status: RECRUITING
-
A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
NCT06642792 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
SMOLY : Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma: Towards New Biomarkers?
NCT03672682 ·Status: COMPLETED
-
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
NCT05100056 ·Status: RECRUITING
-
Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma
NCT01556035 ·Status: COMPLETED ·Phase: PHASE2
-
Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry
NCT04587388 ·Status: RECRUITING
-
Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
NCT03685344 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma
NCT07125872 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
NCT06806488 ·Status: RECRUITING